![Mark Bagnall](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Bagnall
Fundador en Naia Rare Diseases LLC .
Perfil
Mark N.
K.
Bagnall has founded Naia Rare Diseases LLC in 2014, where he holds the title of Chief Operating Officer.
He currently holds the position of Chief Executive Officer at Phenomix Sciences LLC since 2021.
He is also the Chief Executive Officer at Phenomix Sciences, Inc. and the Chairman at XCR Diagnostics, Inc. Additionally, he has been a Director at Ativa Medical Corp.
since 2014.
In his former positions, Mr. Bagnall served as a Director at ThermoGenesis Holdings, Inc. in 2016, Forticell Bioscience, Inc. in 2007-2008, and VIA Pharmaceuticals, Inc. in 2007-2011.
He was also the President & Director at GENTURAdx USA, Inc. in 2011, and held positions at Somatix Therapy Corp., Progenitor, Inc., Mast Therapeutics, Inc., CymaBay Therapeutics, Inc., and Metrika, Inc. Mr. Bagnall obtained his undergraduate degree from the University of California, Berkeley.
Cargos activos de Mark Bagnall
Empresas | Cargo | Inicio |
---|---|---|
Ativa Medical Corp.
![]() Ativa Medical Corp. Medical SpecialtiesHealth Technology Ativa Medical Corp. provides medical diagnostic solutions. It offers analyzers that perform critical hematology and clinical chemistry tests; and disposable test cards for trauma, pediatric, oncology and geriatric patients. The company was founded by David W. Deetz in 2008 and is headquartered in St. Paul, MN. | Director/Miembro de la Junta | 19/11/2014 |
Naia Rare Diseases LLC
![]() Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Naia Rare Diseases, Inc. develops pharmaceutical drugs for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases. The firm offers NB 1001 for adult SBS, NB 1001 for pediatric SBS, and NB 1002, a GLP-2 agonist. The company was founded by H. Daniel Perez and Mark Bagnall in 2014 and is headquartered in Cayman Islands. | Fundador | 01/01/2014 |
XCR Diagnostics, Inc.
![]() XCR Diagnostics, Inc. Medical SpecialtiesHealth Technology XCR Diagnostics, Inc. develops and delivers molecular diagnostic systems. The firm offers assays in development, portable nucleic acid testing, and sample delivery system services. The company was founded in April 2015 and is headquartered in Salt Lake City, UT. | Presidente | - |
Phenomix Sciences LLC
![]() Phenomix Sciences LLC Medical/Nursing ServicesHealth Services Phenomix Sciences LLC engages in the provision of healthcare solutions to enable personalized management of chronic diseases. The company was founded by Andres Acosta and Michael Camilleri in 2017 and is headquartered in St. Paul, MN. | Director Ejecutivo | 01/02/2021 |
Phenomix Sciences, Inc.
![]() Phenomix Sciences, Inc. BiotechnologyHealth Technology Phenomix Sciences, Inc. develops data-driven precision medicine that individualizes obesity treatment. The company is based in Menlo Park, CA. The company was founded by Andres Acosta and Michael Camilleri. The CEO is Mark N. K. Bagnall. | Director Ejecutivo | - |
Antiguos cargos conocidos de Mark Bagnall.
Empresas | Cargo | Fin |
---|---|---|
THERMOGENESIS HOLDINGS, INC. | Director/Miembro de la Junta | 03/11/2016 |
VIA PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/01/2011 |
Mast Therapeutics, Inc.
![]() Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Director Financiero/CFO | 24/08/2009 |
Forticell Bioscience, Inc.
![]() Forticell Bioscience, Inc. BiotechnologyHealth Technology Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ. | Director/Miembro de la Junta | 19/11/2008 |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formación de Mark Bagnall.
University of California, Berkeley | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
THERMOGENESIS HOLDINGS, INC. | Health Technology |
VIA PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 12 |
---|---|
Somatix Therapy Corp.
![]() Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | Health Technology |
Forticell Bioscience, Inc.
![]() Forticell Bioscience, Inc. BiotechnologyHealth Technology Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
Progenitor, Inc.
![]() Progenitor, Inc. BiotechnologyHealth Technology Progenitor, Inc. is an American private company. The firm develops pharmaceutical compounds for nervous system. The company is headquartered in Columbus, OH. | Health Technology |
Mast Therapeutics, Inc.
![]() Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
CymaBay Therapeutics, Inc.
![]() CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
Metrika, Inc.
![]() Metrika, Inc. BiotechnologyHealth Technology Metrika Inc. manufactures and markets disease-monitoring products. It also manufactures other chronic condition products. The company was founded in 1994 by Michael P. Allen and is headquartered in Sunnyvale, CA. | Health Technology |
GENTURAdx USA, Inc.
![]() GENTURAdx USA, Inc. Medical SpecialtiesHealth Technology GENTURAdx USA, Inc. manufactured biotechnology instruments. The firm provided tools necessary for detection and treatment of diseases and drug discoveries. It had offices in the Silicon Valley, Hong Kong, Shanghai and Suzhou. The company was founded by Steve Yu and Jesus Ching in June 2005 and was headquartered in Hayward, CA. | Health Technology |
Ativa Medical Corp.
![]() Ativa Medical Corp. Medical SpecialtiesHealth Technology Ativa Medical Corp. provides medical diagnostic solutions. It offers analyzers that perform critical hematology and clinical chemistry tests; and disposable test cards for trauma, pediatric, oncology and geriatric patients. The company was founded by David W. Deetz in 2008 and is headquartered in St. Paul, MN. | Health Technology |
XCR Diagnostics, Inc.
![]() XCR Diagnostics, Inc. Medical SpecialtiesHealth Technology XCR Diagnostics, Inc. develops and delivers molecular diagnostic systems. The firm offers assays in development, portable nucleic acid testing, and sample delivery system services. The company was founded in April 2015 and is headquartered in Salt Lake City, UT. | Health Technology |
Phenomix Sciences LLC
![]() Phenomix Sciences LLC Medical/Nursing ServicesHealth Services Phenomix Sciences LLC engages in the provision of healthcare solutions to enable personalized management of chronic diseases. The company was founded by Andres Acosta and Michael Camilleri in 2017 and is headquartered in St. Paul, MN. | Health Services |
Naia Rare Diseases LLC
![]() Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Naia Rare Diseases, Inc. develops pharmaceutical drugs for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases. The firm offers NB 1001 for adult SBS, NB 1001 for pediatric SBS, and NB 1002, a GLP-2 agonist. The company was founded by H. Daniel Perez and Mark Bagnall in 2014 and is headquartered in Cayman Islands. | Health Services |
Phenomix Sciences, Inc.
![]() Phenomix Sciences, Inc. BiotechnologyHealth Technology Phenomix Sciences, Inc. develops data-driven precision medicine that individualizes obesity treatment. The company is based in Menlo Park, CA. The company was founded by Andres Acosta and Michael Camilleri. The CEO is Mark N. K. Bagnall. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Bagnall